These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11943386)

  • 1. Guar-based monolithic matrix systems: effect of ionizable and non-ionizable substances and excipients on gel dynamics and release kinetics.
    Dürig T; Fassihi R
    J Control Release; 2002 Apr; 80(1-3):45-56. PubMed ID: 11943386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride.
    Krishnaiah YS; Karthikeyan RS; Gouri Sankar V; Satyanarayana V
    J Control Release; 2002 May; 81(1-2):45-56. PubMed ID: 11992677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of macromolecular changes and drug release from hydrophilic matrix systems.
    Jamzad S; Tutunji L; Fassihi R
    Int J Pharm; 2005 Mar; 292(1-2):75-85. PubMed ID: 15725555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydration, erosion, and release behavior of guar-based hydrophilic matrix tablets containing total alkaloids of Sophora alopecuroides.
    Zhao W; Song L; Deng H; Yao H
    Drug Dev Ind Pharm; 2009 May; 35(5):594-602. PubMed ID: 19040179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of guar gum in the preparation of sustained-release matrix tablets.
    Khullar P; Khar RK; Agarwal SP
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1095-9. PubMed ID: 9876566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified guar galactomannan as an improved pharmaceutical excipient.
    Gebert MS; Friend DR
    Pharm Dev Technol; 1998 Aug; 3(3):315-23. PubMed ID: 9742552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate.
    Krishnaiah YS; Karthikeyan RS; Satyanarayana V
    Int J Pharm; 2002 Jul; 241(2):353-66. PubMed ID: 12100863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ionic crosslink on the release of metronidazole from partially carboxymethylated guar gum tablet.
    Singh R; Maity S; Sa B
    Carbohydr Polym; 2014 Jun; 106():414-21. PubMed ID: 24721097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.
    Gohel MC; Sumitra G M
    J Control Release; 2002 Feb; 79(1-3):157-64. PubMed ID: 11853927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of floating and sticking extended release delivery systems: an unconventional dissolution test.
    Dürig T; Fassihi R
    J Control Release; 2000 Jun; 67(1):37-44. PubMed ID: 10773327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the development of colon-targeted delivery systems for celecoxib in the prevention of colorectal cancer.
    Krishnaiah YS; Satyanarayana V; Kumar BD; Karthikeyan RS
    J Drug Target; 2002 May; 10(3):247-54. PubMed ID: 12075826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
    Rajesh KS; Venkataraju MP; Gowda DV
    Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation development and in-vitro evaluation of gastroretentive drug delivery system of loxoprofen sodium: A natural excipients based approach.
    Zaman M; Akhtar F; Baseer A; Hasan SMF; Aman W; Khan A; Badshah M; Majeedullah -
    Pak J Pharm Sci; 2021 Jan; 34(1):57-63. PubMed ID: 34248003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS).
    Matharu AS; Motto MG; Patel MR; Simonelli AP; Dave RH
    J Pharm Sci; 2011 Jan; 100(1):150-63. PubMed ID: 20572054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low swelling, crosslinked guar and its potential use as colon-specific drug carrier.
    Gliko-Kabir I; Yagen B; Penhasi A; Rubinstein A
    Pharm Res; 1998 Jul; 15(7):1019-25. PubMed ID: 9688054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol-resistant ethylcellulose/guar gum coatings--importance of formulation parameters.
    Rosiaux Y; Velghe C; Muschert S; Chokshi R; Leclercq B; Siepmann F; Siepmann J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1250-8. PubMed ID: 23891769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel use of similarity factors f2 and Sd for the development of diltiazem HCl modified-release tablets using a 3(2) factorial design.
    Gohel MC; Panchal MK
    Drug Dev Ind Pharm; 2002 Jan; 28(1):77-87. PubMed ID: 11858527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of selected polysaccharide excipients in buccoadhesive tablets for sustained release of nicotine.
    Park CR; Munday DL
    Drug Dev Ind Pharm; 2004 Jul; 30(6):609-17. PubMed ID: 15285334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.